Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.
Allscripts is one of the largest public companies focused exclusively on healthcare information technology globally. Allscripts offers healthcare providers, payers and life sciences companies globally a complete portfolio of clinical, financial, population health management, transaction and managed IT services and other solutions. As of December 31, 2018, we had approximately 9,500 employees worldwide. For 2018, non-GAAP revenue was $2.1 billion. We have clients and operations in 17 countries including Australia, Canada, India, Israel and the United Kingdom.
Our industry leading client base consists of over 75,000 physician practices, 3,400 hospitals and 17.5 million connected consumers through FollowMyHealth®.
We invite investors to learn more about Allscripts and the impact we have on health care around the globe - To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog. Or please contact Stephen Shulstein, Vice President of Investor Relations at Stephen.firstname.lastname@example.org.
|03/19/19||Pulse8 joins the Health Plan Alliance Group Purchasing Organization with its ground-breaking Formul8™ solution for managing Pharmacy Costs|
|NASHVILLE, March 19, 2019 (GLOBE NEWSWIRE) -- Pulse8, part of Veradigm™, an Allscripts (NASDAQ: MDRX) business unit, the first – and ONLY one with a patent pending – healthcare analytics and technology company delivering complete visibility into the efficacy of Risk Adjustment, Quality Management, and Pharmacy Benefit Management programs, is excited to become the latest collaborating partner within the Health Plan Alliance Group Purchasing Organization (GPO). Pulse8 will be offering its Formul... |
|03/18/19||Pulse8 extends the Utility and Technology of its powerful analytic engine, Illumin8 Active Intelligence™ platform|
|NASHVILLE, March 18, 2019 (GLOBE NEWSWIRE) -- Pulse8, part of Veradigm™, an Allscripts (NASDAQ: MDRX) business unit, the first – and ONLY one with a patent pending – healthcare analytics and technology company delivering complete visibility into the efficacy of Risk Adjustment, Quality Management, and Pharmacy Benefit Management programs, proudly debuted several significant enhancements to its illumin8 Solution Suite this quarter – most notably, the advent of an ACO-specific module to their fl... |
|03/14/19||Allscripts Partners with Opargo to Drive Improved Patient Care through Optimized Practice Management|
|A predictive analytics and optimization engine fully integrated with Allscripts Practice Management to improve scheduling capabilities and practice workflows
CHICAGO, March 14, 2019 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ:MDRX) announced a strategic partnership with Opargo focused on delivering integrated technology to improve health care efficiency and reduce schedule churn through real-time schedule optimization.
Allscripts has long held and invested in the fact that health care is... |
|03/13/19||Veradigm™ Strengthens its Health Plan and Analytics Solutions by Finalizing Partnership with Pulse8|
|CHICAGO, March 13, 2019 (GLOBE NEWSWIRE) -- Veradigm™, an Allscripts (NASDAQ: MDRX), business unit, announced today that it has strengthened its strategic relationship with Pulse8, a leader in healthcare analytics and technology company.
Pulse8 is the first, and only with a patent pending, healthcare analytics and technology company delivering a complete enterprise platform to provide visibility into the efficacy of Risk Adjustment, Quality Improvement, and Pharmacy Management programs. Pu... |
|02/21/19 4:30 p.m. ET|
|01/07/19 4:00 p.m. PT|